Clinical Trial Update: A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones [NA]

View source ↗

Summary

The randomized trial assessing whether alfuzosin (Xatral) helps in the passage of kidney stones has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Stones

Drugs mentioned

• Xatral (alfuzosin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Kidney Stones | NA | Status: WITHDRAWN